Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DX26FENTY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $11,094
Award facts
- Contract value 100% obligated
- $11,094.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $11,094.20 on October 30, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, without set-aside designation, represents one of numerous purchase orders issued to the vendor in October 2025 for pharmaceutical products and medical consumables to support Department of Defense healthcare operations. The award falls under DMS Pharmaceutical Group's broader Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, specifically the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative.
DMS Pharmaceutical Group serves as a critical pharmaceutical supplier within the federal military medical system, with its IDC authorization allowing the Defense Logistics Agency to issue delivery orders for a comprehensive portfolio including branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and medical consumables. The underlying IDC, awarded on November 13, 2025, carries a ceiling value of $499,999,999 with a completion date of December 31, 2036, positioning the company as one of multiple regional prime vendor contractors under the broader $30.3 billion PPV-G GEN V acquisition strategy. The company's established performance across diverse product categories and therapeutic areas demonstrates its capability to fulfill specialized pharmaceutical requirements for military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DX26FENTY?
SPE2DX26FENTY was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on October 30, 2025.
How much is contract SPE2DX26FENTY worth?
The government has obligated $11,094 on SPE2DX26FENTY.
Is contract SPE2DX26FENTY an order under another contract?
Yes. SPE2DX26FENTY is a delivery order under SPE2DX16D9411, an indefinite delivery contract.
Was contract SPE2DX26FENTY competed?
The extent of competition for SPE2DX26FENTY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award